Web Results

en.wikipedia.org/wiki/Bruesewitz_v._Wyeth

Bruesewitz v. Wyeth, 562 U.S. 223 (2011), is a United States Supreme Court case that decided whether a section of the National Childhood Vaccine Injury Act of 1986 preempts all vaccine design defect claims against vaccine manufacturers .

www.americanbar.org/newsletter/publications/aba_health_esource_home/aba_health_law_esource_1104_brown.html

Bruesewitz v. Wyeth's Impact on the Vaccine Safety Debate. By Erin C. Fuse Brown1 & Jalayne J. Arias2, Public Health Law and Policy Program at Sandra Day ...

www.oyez.org/cases/2010/09-152

Oct 12, 2010 ... Bruesewitz v. ... Wyeth, Inc., fka Wyeth Laboratories, et al. ... The Bruesewitzes filed a lawsuit against Wyeth in state court in Pennsylvania.

www.ncbi.nlm.nih.gov/pmc/articles/PMC3753291

Mar 22, 2011 ... Claude-Édouard Châtillon,a,* Rina Zelmann,b Aleksandra Bortel,b .... A comparison of HFO duration versus contact size was also performed. Go to: 2. Methods. The intraperitoneal pilocarpine rat model was used (Turski et al., 1983). ... and ketamine (50 mg/kg IP: Wyeth, Canada), injected separately.

www.ncbi.nlm.nih.gov/pmc/articles/PMC4878906

Aug 1, 2010 ... Aleksandra Bortel,a Maxime Lévesque,a Giuseppe Biagini,b Jean ... However, little effort (but see Biagini et al., 2006; Klitgaard et al., ... ketamine (50 mg/kg, i.p.; Wyeth, Canada) (Martin and Kapur, 2008). .... **p<0.01 between latent period versus chronic period; LSD test after significant two-way ANOVA.

www.ncbi.nlm.nih.gov/pmc/articles/PMC4686797

Dec 22, 2015 ... To resolve this apparent inconsistency, Wang et al. ... xylazine (10 mg/kg i.p.; Bayer Inc., Canada) and ketamine (50 mg/kg i.p.; Wyeth, Canada).

pdfs.semanticscholar.org/e4e0/f59b13a67e0f022c7114a51dd52418b90512.pdf

Oct 28, 2009 ... Schack-Nielsen et al. [14] found that PWV ... point on the pulse wave, averaged for all acceptable waveforms over a period of 10 s .... mothers drank alcohol versus 8.9 years of age for the oth- ers. ..... and Health, Zonta International, Wyeth Pharmaceuticals and ... 11 Laurent S, Cockcroft J, Van Bortel L, Bou-.

europepmc.org/articles/pmc5006195

Mar 15, 2016 ... All filorexant doses (2.5/5/10/20mg) were significantly superior to placebo in ... for 4 weeks (Herring et al., 2012), almorexant (singe-dose) (Hoever et al., 2012), .... with 95% CIs provided for comparisons of treatment vs placebo. ..... Syrex, Takeda, TransOral, Wyeth, and Xenoport; has acted as a consultant ...

citeseerx.ist.psu.edu/viewdoc/download?doi=10.1.1.880.6040&rep=rep1&type=pdf

Drugs were supplied by the Lemmon Co, Sellersville, PA; Wyeth Laboratories/ .... 80 years versus other ages ... is consistent with the observations of Chae et al in a lower ..... Bortel LM: Short- and long-term effects of smoking on arterial wall.